Chronic Kidney Disease (CKD) is a widespread and frequently under recognised condition impacting millions around the globe. With an ageing population, the prevalence of CKD is projected to rise ...
Hebrew University researchers test paricalcitol for treating CKD in dogs, showing promise against proteinuria. Study ...
A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...
Akebia Therapeutics, Inc.’s AKBA share price has dipped by 22.21%, which has investors questioning if this is right time to ...
Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...
Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an ...
The number of end-stage kidney disease patients undergoing chronic dialysis could double to more than 106,000 patients by ...
Discover scPharmaceuticals' Q4 2024 achievements, including FUROSCIX's CKD approval, Medicare redesign insights, and strategies for 2025 growth.
Uganda has made significant strides in kidney care, including the establishment of dialysis centres and successful kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback